Global Spirometer Market is Expected to Reach USD 858.6 Million by 2020

Date: 2015-10-15

A spirometer is an instrument used to measure the air inhaled into and exhaled out of the lungs. It provides a simple of way of measuring lung volume and capacity, and is used in pulmonary tests. It helps in diagnosing respiratory diseases (such as asthma, bronchitis, emphysema, and COPD), shortness of breath, exposure to chemicals at work, lung function before surgery, effect of medication, and progress in disease treatment. 

Most spirometers depict a volume time graph and a flow volume graph, which help in examining a patient’s pulmonary functions. The application of spirometers has become easier with the help of technological advancements in the field of respiratory care devices. Key factors influencing the growth of the market in the U.S. and Europe are policies mandating the use of respiratory devices, and lack of awareness of respiratory diseases and their symptoms.

The global spirometer market is expected to reach USD 858.6 million by 2020, at a CAGR of 9.8% from 2015 to 2020. Growing aging population, rising incidences of chronic obtrusive pulmonary diseases (COPD), technological advancements in the field of respiratory care devices, and tight budgets of healthcare institutions are major factors influencing the growth of the spirometer market.

A spirometer is used to measure airway obstructions among patients exhibiting symptoms of respiratory disorders. Usage of spirometry in primary care is expected to be helpful in certain cases, wherein it provides accurate results. Self-monitoring by a spirometer lead to early detection of acute exacerbations of chronic obstructive pulmonary disease (COPD) however, it requires training and supervising of high-quality spirometer by experts.

The global spirometer market report studies major regions, such as North America, Europe, Asia-Pacific, and rest of the world (RoW).

In 2015, North America is expected to account for the largest share of 41% of the global spirometer market. One of the main factors contributing to this high share is the increase in smoking population and rise in the number of asthma and COPD patients. However, fluctuating reimbursement rates, stringent regulations for medical devices, and high cost of spirometers are factors restricting its market growth.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are CareFusion (U.S.), Philips Healthcare (Netherlands), Schiller (Switzerland), Welch Allyn, Inc. (U.S.), SDI Diagnostics (U.S.), Cardiotech (Australia), MIR Medical International Research S.r.l (Italy), Vitalograph (U.K.), MGC Diagnostics Corporation (U.S.), NDD Medical Technologies (U.S.), SDI Diagnostics (U.S.), Jones Medical Corporation (U.S.), Gerathern Respiratory GmbH (Germany), Thor Medical Systems (Hungary), Fukuda Sangyo Inc. (Philippines), Nihon Kohden Corporation (Japan), and nSpire Health Inc. (Germany), among others.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample